Date,Articles
2014-01-13,"{""abstract"": ""Genzyme, the American biotechnology unit of the French drug maker Sanofi, is buying a 12 percent stake in Alnylam Pharmaceuticals for $700 million as part of an expanded alliance to develop treatments for rare genetic diseases."", ""web_url"": ""https://dealbook.nytimes.com/2014/01/13/sanofi-unit-to-buy-700-million-stake-in-rare-disease-company/"", ""snippet"": ""Genzyme, the American biotechnology unit of the French drug maker Sanofi, is buying a 12 percent stake in Alnylam Pharmaceuticals for $700 million as part of an expanded alliance to develop treatments for rare genetic diseases."", ""lead_paragraph"": ""LONDON \u2013 The biotechnology unit of the French drug maker Sanofi\u00a0 agreed on Monday to buy a 12 percent stake in Alnylam Pharmaceuticals for $700 million as part of an expanded alliance to develop treatments for rare genetic diseases."", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Sanofi Unit to Buy $700 Million Stake in Rare Disease Company"", ""kicker"": ""DealBook"", ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Alnylam Pharmaceuticals Inc"", ""rank"": 3, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Genzyme Corp"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 5, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""France"", ""rank"": 6, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""Massachusetts"", ""rank"": 7, ""major"": ""N""}], ""pub_date"": ""2014-01-13T11:52:54+0000"", ""document_type"": ""article"", ""news_desk"": """", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Chad Bray"", ""person"": [{""firstname"": ""Chad"", ""middlename"": null, ""lastname"": ""Bray"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/68a6ec8e-aa6c-579b-9963-ca4f2188f4a7"", ""word_count"": 228, ""uri"": ""nyt://article/68a6ec8e-aa6c-579b-9963-ca4f2188f4a7""}"
2014-04-28,"{""abstract"": ""Sanofi conducted a test of its vaccine for dengue fever, which affects 50 million to 100 million people annually, that involved 10,000 children in Southeast Asia."", ""web_url"": ""https://www.nytimes.com/2014/04/29/business/international/sanofi-says-dengue-vaccine-succeeds-in-late-stage-trial.html"", ""snippet"": ""Sanofi conducted a test of its vaccine for dengue fever, which affects 50 million to 100 million people annually, that involved 10,000 children in Southeast Asia."", ""lead_paragraph"": ""The French pharmaceutical company Sanofi said on Monday that its experimental vaccine for dengue fever had succeeded in its first late-stage clinical trial. The results could help pave the way for the introduction of the first vaccine to prevent a disease that afflicts an estimated 50 million to 100 million people a year. "", ""print_section"": ""B"", ""print_page"": ""3"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/04/29/business/Fever1/Fever1-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2014/04/29/business/Fever1/Fever1-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/04/29/business/Fever1/Fever1-jumbo.jpg"", ""height"": 683, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/04/29/business/Fever1/Fever1-superJumbo.jpg"", ""height"": 1366, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/04/29/business/Fever1/Fever1-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2014/04/29/business/Fever1/Fever1-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/04/29/business/Fever1/Fever1-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Results Are Promising in Clinical Trial of Dengue Fever Vaccine"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Results Are Promising in Clinical Trial of Dengue Fever Vaccine"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Vaccination and Immunization"", ""rank"": 2, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Dengue Fever"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Clinical Trials"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 6, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""Far East, South and Southeast Asia and Pacific Areas"", ""rank"": 7, ""major"": ""N""}], ""pub_date"": ""2014-04-28T08:12:30+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""International Business"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/6f1b13cd-e7c8-5164-8f0d-cf88a7c466cd"", ""word_count"": 708, ""uri"": ""nyt://article/6f1b13cd-e7c8-5164-8f0d-cf88a7c466cd""}"
2014-05-28,"{""abstract"": ""The French company Sanofi is buying global rights from Lilly to sell the erectile dysfunction drug after its patents expire."", ""web_url"": ""https://www.nytimes.com/2014/05/29/business/eli-lilly-takes-step-toward-making-cialis-an-over-the-counter-drug.html"", ""snippet"": ""The French company Sanofi is buying global rights from Lilly to sell the erectile dysfunction drug after its patents expire."", ""lead_paragraph"": ""Men with erectile dysfunction may be able to avoid the awkwardness of a doctor\u2019s visit by buying the drug Cialis without a prescription, under a proposal announced Wednesday by the drug\u2019s maker, Eli Lilly, and the French pharmaceutical company Sanofi."", ""print_section"": ""B"", ""print_page"": ""5"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/05/29/business/cialis/cialis-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2014/05/29/business/cialis/cialis-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/05/29/business/cialis/cialis-jumbo.jpg"", ""height"": 682, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/05/29/business/cialis/cialis-superJumbo.jpg"", ""height"": 1067, ""width"": 1601, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/05/29/business/cialis/cialis-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2014/05/29/business/cialis/cialis-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/05/29/business/cialis/cialis-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""A Plan to Sell Cialis, an Erectile Drug, Over the Counter"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Plan to Sell an Erectile Drug Over the Counter"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Thomas, Katie"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Eli Lilly and Company"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Cialis (Drug)"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Food and Drug Administration"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Impotence"", ""rank"": 6, ""major"": ""N""}], ""pub_date"": ""2014-05-28T18:01:56+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Katie Thomas"", ""person"": [{""firstname"": ""Katie"", ""middlename"": null, ""lastname"": ""Thomas"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/e37576f3-03c7-5cfe-a730-87337edcf73e"", ""word_count"": 568, ""uri"": ""nyt://article/e37576f3-03c7-5cfe-a730-87337edcf73e""}"
2014-09-03,"{""abstract"": ""A French drug company said that use of the vaccine cut the risk of getting dengue by 60.8 percent and those vaccinated had an 80 percent lower risk of being hospitalized for the disease."", ""web_url"": ""https://www.nytimes.com/2014/09/04/business/experimental-vaccine-shows-promise-against-dengue-fever.html"", ""snippet"": ""A French drug company said that use of the vaccine cut the risk of getting dengue by 60.8 percent and those vaccinated had an 80 percent lower risk of being hospitalized for the disease."", ""lead_paragraph"": ""An experimental vaccine against dengue fever being developed by Sanofi proved about 60 percent effective in its second large clinical trial. The results could clear the way for the introduction of the world\u2019s first inoculation against the disease, which is mosquito-borne and becoming an increasing threat."", ""print_section"": ""B"", ""print_page"": ""1"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-articleLarge-v2.jpg"", ""height"": 388, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-articleLarge-v2.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 388}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-jumbo-v2.jpg"", ""height"": 662, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-superJumbo-v2.jpg"", ""height"": 1325, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-thumbStandard-v2.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-thumbStandard-v2.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/09/04/business/04drug-pic1/04drug-pic1-thumbLarge-v2.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""First Vaccine for Dengue Fever Shows Promise in 2nd Big Trial"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""First Vaccine for Dengue Fever Shows Promise in 2nd Big Trial"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Dengue Fever"", ""rank"": 1, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Vaccination and Immunization"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Preventive Medicine"", ""rank"": 6, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Mosquitoes"", ""rank"": 7, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Clinical Trials"", ""rank"": 8, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Tests (Medical)"", ""rank"": 9, ""major"": ""N""}], ""pub_date"": ""2014-09-03T16:02:02+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/00038bd9-ca00-50bb-be5e-b181b74a53ed"", ""word_count"": 842, ""uri"": ""nyt://article/00038bd9-ca00-50bb-be5e-b181b74a53ed""}"
2014-10-29,"{""abstract"": ""Sanofi\u2019s board said it was dissatisfied by its relationship with Christopher Viehbacher, who had led the French pharmaceutical company since 2008."", ""web_url"": ""https://www.nytimes.com/2014/10/30/business/international/christopher-viehbacher-sanofi-chief-ousted-by-board.html"", ""snippet"": ""Sanofi\u2019s board said it was dissatisfied by its relationship with Christopher Viehbacher, who had led the French pharmaceutical company since 2008."", ""lead_paragraph"": ""PARIS \u2014 After the French drug maker Sanofi abruptly fired its outspoken chief executive, Christopher A. Viehbacher, on Wednesday, its chairman said the company would continue its international strategy \u2014 a focus that Mr. Viehbacher was often criticized for in France."", ""print_section"": ""B"", ""print_page"": ""4"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-articleLarge.jpg"", ""height"": 384, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 384}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-jumbo.jpg"", ""height"": 655, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-superJumbo.jpg"", ""height"": 1310, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2014/10/30/business/30sanofi-pic1/30sanofi-pic1-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Sanofi Fires Its Chief Executive but Retains His Global Strategy"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Frustrated by Communication, Sanofi Fires C.E.O. but Retains His Global Strategy"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 1, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Jolly, David"", ""rank"": 2, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Viehbacher, Christopher A"", ""rank"": 3, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Appointments and Executive Changes"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 6, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Genzyme Corp"", ""rank"": 7, ""major"": ""N""}], ""pub_date"": ""2014-10-29T10:46:55+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""International Business"", ""byline"": {""original"": ""By David Jolly and Andrew Pollack"", ""person"": [{""firstname"": ""David"", ""middlename"": null, ""lastname"": ""Jolly"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}, {""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 2}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/678d5494-5b95-568e-b4eb-9f965e6387fa"", ""word_count"": 870, ""uri"": ""nyt://article/678d5494-5b95-568e-b4eb-9f965e6387fa""}"
2015-02-20,"{""abstract"": ""Olivier Brandicourt, head of Bayer\u2019s health care business, will have to restore growth in Sanofi\u2019s important diabetes franchise."", ""web_url"": ""https://www.nytimes.com/2015/02/20/business/after-shake-up-last-year-sanofi-names-new-chief.html"", ""snippet"": ""Olivier Brandicourt, head of Bayer\u2019s health care business, will have to restore growth in Sanofi\u2019s important diabetes franchise."", ""lead_paragraph"": ""The French pharmaceutical giant Sanofi on Thursday named Olivier Brandicourt, a top executive at Bayer, as its new chief executive, replacing Christopher A. Viehbacher, who was fired in October. "", ""print_section"": ""B"", ""print_page"": ""10"", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""After Shake-Up Last Year, Sanofi Names New Chief "", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""After Shake-Up Last Year, Sanofi Names New Chief"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 2, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Viehbacher, Christopher A"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Appointments and Executive Changes"", ""rank"": 4, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Brandicourt, Olivier"", ""rank"": 5, ""major"": ""N""}], ""pub_date"": ""2015-02-20T02:18:52+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/b96f7165-f24b-50db-a722-b3ff56ad7c27"", ""word_count"": 547, ""uri"": ""nyt://article/b96f7165-f24b-50db-a722-b3ff56ad7c27""}"
2015-03-15,"{""abstract"": ""Researchers cautioned, however, that the studies were small and meant to assess whether the drugs safely lowered cholesterol, not whether they staved off heart attacks."", ""web_url"": ""https://www.nytimes.com/2015/03/16/business/tests-of-cholesterol-drugs-offer-hope-of-reducing-heart-attacks-and-strokes.html"", ""snippet"": ""Researchers cautioned, however, that the studies were small and meant to assess whether the drugs safely lowered cholesterol, not whether they staved off heart attacks."", ""lead_paragraph"": ""A new class of experimental cholesterol drugs might sharply reduce the risk of heart attacks and strokes, researchers reported on Sunday, citing what they described as preliminary evidence."", ""print_section"": ""B"", ""print_page"": ""3"", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Cholesterol"", ""rank"": 1, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""New England Journal of Medicine"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Heart"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Stroke"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 6, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""AMGEN INC"", ""rank"": 7, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Regeneron Pharmaceuticals Inc"", ""rank"": 8, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 9, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Statins (Cholesterol-Lowering Drugs)"", ""rank"": 10, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Nissen, Steven E"", ""rank"": 11, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Cleveland Clinic"", ""rank"": 12, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""Los Angeles (Calif)"", ""rank"": 13, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""San Diego (Calif)"", ""rank"": 14, ""major"": ""N""}], ""pub_date"": ""2015-03-15T15:54:35+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/6fa258ac-aa43-5fad-8a2e-73dafe509b43"", ""word_count"": 981, ""uri"": ""nyt://article/6fa258ac-aa43-5fad-8a2e-73dafe509b43""}"
2015-07-24,"{""abstract"": ""The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price."", ""web_url"": ""https://www.nytimes.com/2015/07/25/business/us-approves-drug-that-can-sharply-lower-cholesterol-levels.html"", ""snippet"": ""The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price."", ""lead_paragraph"": ""Federal regulators on Friday approved the first of a new class of drug that can sharply lower cholesterol levels, offering a new option for millions of Americans suffering from cardiovascular disease, the nation\u2019s leading killer."", ""print_section"": ""B"", ""print_page"": ""1"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/25/business/25drug-web/25drug-web-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2015/07/25/business/25drug-web/25drug-web-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/25/business/25drug-web/25drug-web-jumbo.jpg"", ""height"": 683, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/25/business/25drug-web/25drug-web-superJumbo.jpg"", ""height"": 1366, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/25/business/25drug-web/25drug-web-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2015/07/25/business/25drug-web/25drug-web-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/25/business/25drug-web/25drug-web-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""New Drug Sharply Lowers Cholesterol, but It\u2019s Costly"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""New Drug Sharply Lowers Cholesterol, but It&#8217;s Costly "", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Praluent (Drug)"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Regeneron Pharmaceuticals Inc"", ""rank"": 3, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Cholesterol"", ""rank"": 6, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Food and Drug Administration"", ""rank"": 7, ""major"": ""N""}], ""pub_date"": ""2015-07-24T18:33:00+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/12d0557b-5aaf-50da-af56-f9b77e4c15e6"", ""word_count"": 1294, ""uri"": ""nyt://article/12d0557b-5aaf-50da-af56-f9b77e4c15e6""}"
2015-07-28,"{""abstract"": ""The French pharmaceutical giant Sanofi will be partnering with the biotech company Regeneron Pharmaceuticals to develop drugs that harness the body\u2019s immune system to fight cancer."", ""web_url"": ""https://www.nytimes.com/2015/07/28/business/sanofi-to-join-regeneron-in-quest-to-unleash-immune-system-on-cancer.html"", ""snippet"": ""The French pharmaceutical giant Sanofi will be partnering with the biotech company Regeneron Pharmaceuticals to develop drugs that harness the body\u2019s immune system to fight cancer."", ""lead_paragraph"": ""The French pharmaceutical giant Sanofi will pay at least $1.7 billion to enter a new collaboration with Regeneron Pharmaceuticals, this one aimed at developing drugs that harness the body\u2019s immune system to fight cancer."", ""print_section"": ""B"", ""print_page"": ""2"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/29/business/29SANOFI/29SANOFI-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2015/07/29/business/29SANOFI/29SANOFI-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/29/business/29SANOFI/29SANOFI-jumbo.jpg"", ""height"": 683, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/29/business/29SANOFI/29SANOFI-superJumbo.jpg"", ""height"": 1365, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/29/business/29SANOFI/29SANOFI-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2015/07/29/business/29SANOFI/29SANOFI-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/07/29/business/29SANOFI/29SANOFI-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Sanofi to Join Regeneron in Quest to Unleash Immune System on Cancer"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Sanofi Joins Regeneron to Develop New Drugs"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Regeneron Pharmaceuticals Inc"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Immunotherapy"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Cancer"", ""rank"": 6, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Immune System"", ""rank"": 7, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Biotechnology and Bioengineering"", ""rank"": 8, ""major"": ""N""}], ""pub_date"": ""2015-07-28T05:00:03+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/5e157dbb-8d70-5af8-bda0-9759377240c9"", ""word_count"": 527, ""uri"": ""nyt://article/5e157dbb-8d70-5af8-bda0-9759377240c9""}"
2015-09-08,"{""abstract"": ""A report from the Institute for Clinical and Economic Review says the prices on two drugs to fight cholesterol that cost more than $14,000 a year should be slashed."", ""web_url"": ""https://www.nytimes.com/2015/09/09/business/new-cholesterol-drugs-are-vastly-overpriced-analysis-says.html"", ""snippet"": ""A report from the Institute for Clinical and Economic Review says the prices on two drugs to fight cholesterol that cost more than $14,000 a year should be slashed."", ""lead_paragraph"": ""Two powerful new drugs that can sharply lower cholesterol are vastly overpriced based on the value they provide, according to a new analysis by an independent organization that evaluates pharmaceutical costs."", ""print_section"": ""A"", ""print_page"": ""3"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/09/09/business/09drug-web1/09drug-web1-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2015/09/09/business/09drug-web1/09drug-web1-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/09/09/business/09drug-web1/09drug-web1-jumbo.jpg"", ""height"": 600, ""width"": 900, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/09/09/business/09drug-web1/09drug-web1-superJumbo.jpg"", ""height"": 600, ""width"": 900, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/09/09/business/09drug-web1/09drug-web1-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2015/09/09/business/09drug-web1/09drug-web1-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/09/09/business/09drug-web1/09drug-web1-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""New Cholesterol Drugs Are Vastly Overpriced, Analysis Says"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""New Cholesterol Drugs Are Overpriced, Analysis Finds"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Institute for Clinical and Economic Review"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Cholesterol"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""AMGEN INC"", ""rank"": 5, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 6, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Prices (Fares, Fees and Rates)"", ""rank"": 7, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Health Insurance and Managed Care"", ""rank"": 8, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Praluent (Drug)"", ""rank"": 9, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Repatha (Drug)"", ""rank"": 10, ""major"": ""N""}], ""pub_date"": ""2015-09-08T21:24:28+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/3341e2ca-33ad-5fb4-8f9f-8a5b0d271d2a"", ""word_count"": 825, ""uri"": ""nyt://article/3341e2ca-33ad-5fb4-8f9f-8a5b0d271d2a""}"
2015-10-06,"{""abstract"": ""Rather than bargain with a single maker, the pharmacy benefits manager says it will offer both Repatha and Praluent, promising but expensive products."", ""web_url"": ""https://www.nytimes.com/2015/10/07/business/express-scripts-says-it-will-cover-2-new-cholesterol-drugs.html"", ""snippet"": ""Rather than bargain with a single maker, the pharmacy benefits manager says it will offer both Repatha and Praluent, promising but expensive products."", ""lead_paragraph"": ""The nation\u2019s largest manager of drug prescriptions said on Tuesday that it would pay for two drugs in a promising new class of cholesterol-lowering medicines, rather than choose one over the other in an effort to lower costs."", ""print_section"": ""B"", ""print_page"": ""4"", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Express Scripts Says It Will Cover 2 New Cholesterol Drugs"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Express Scripts Will Cover 2 New Cholesterol Drugs"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""organizations"", ""value"": ""Express Scripts Inc"", ""rank"": 1, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 2, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Repatha (Drug)"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Praluent (Drug)"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Cholesterol"", ""rank"": 6, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""AbbVie Inc"", ""rank"": 7, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 8, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Gilead Sciences Inc"", ""rank"": 9, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""AMGEN INC"", ""rank"": 10, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Regeneron Pharmaceuticals Inc"", ""rank"": 11, ""major"": ""N""}], ""pub_date"": ""2015-10-06T21:00:42+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/1d43e58f-d265-5687-8309-22251685ed46"", ""word_count"": 772, ""uri"": ""nyt://article/1d43e58f-d265-5687-8309-22251685ed46""}"
2015-11-13,"{""abstract"": ""A lawsuit claims that a giant French pharmaceutical favored its own multiple sclerosis treatment to avoid making a huge payout."", ""web_url"": ""https://www.nytimes.com/2015/11/15/business/after-merger-two-competing-drugs-and-billion-dollar-questions.html"", ""snippet"": ""A lawsuit claims that a giant French pharmaceutical favored its own multiple sclerosis treatment to avoid making a huge payout."", ""lead_paragraph"": ""The investing world is riddled with conflicts of interest that can surprise even the most sophisticated investor. Learning that lesson the hard way are holders of an instrument issued in 2011 when Sanofi, the giant French pharmaceutical company, took over Genzyme, a biotech concern based in Cambridge, Mass."", ""print_section"": ""BU"", ""print_page"": ""1"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/11/15/business/gret-web1/gret-web1-articleLarge.jpg"", ""height"": 424, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2015/11/15/business/gret-web1/gret-web1-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 424}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/11/15/business/gret-web1/gret-web1-jumbo.jpg"", ""height"": 723, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/11/15/business/gret-web1/gret-web1-superJumbo.jpg"", ""height"": 1446, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/11/15/business/gret-web1/gret-web1-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2015/11/15/business/gret-web1/gret-web1-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/11/15/business/gret-web1/gret-web1-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""After Merger, Two Competing Drugs and Billion-Dollar Questions"", ""kicker"": ""Fair Game"", ""content_kicker"": null, ""print_headline"": ""One Merger, Two Drugs, Millions Lost"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Morgenson, Gretchen"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Genzyme Corp"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Suits and Litigation (Civil)"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 6, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Multiple Sclerosis"", ""rank"": 7, ""major"": ""N""}], ""pub_date"": ""2015-11-13T14:04:11+0000"", ""document_type"": ""article"", ""news_desk"": ""SundayBusiness"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Gretchen Morgenson"", ""person"": [{""firstname"": ""Gretchen"", ""middlename"": null, ""lastname"": ""Morgenson"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/3e6c8b3e-ffa5-5e9d-a4cf-86642dce8d13"", ""word_count"": 1020, ""uri"": ""nyt://article/3e6c8b3e-ffa5-5e9d-a4cf-86642dce8d13""}"
2015-12-09,"{""abstract"": ""The vaccine, called Dengvaxia, has been developed by Sanofi. Dengue fever can cause high temperature and intense joint and muscle pain."", ""web_url"": ""https://www.nytimes.com/2015/12/10/business/first-dengue-fever-vaccine-approved-by-mexico.html"", ""snippet"": ""The vaccine, called Dengvaxia, has been developed by Sanofi. Dengue fever can cause high temperature and intense joint and muscle pain."", ""lead_paragraph"": ""A dengue fever vaccine developed by the French pharmaceutical giant Sanofi has been approved for use by Mexico, the first approval in the world for any vaccine for the disease, which afflicts tens of millions of people around the world and is becoming an increasing threat."", ""print_section"": ""B"", ""print_page"": ""2"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/10/business/10dengue-web/10dengue-web-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2015/12/10/business/10dengue-web/10dengue-web-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/10/business/10dengue-web/10dengue-web-jumbo.jpg"", ""height"": 682, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/10/business/10dengue-web/10dengue-web-superJumbo.jpg"", ""height"": 1365, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/10/business/10dengue-web/10dengue-web-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2015/12/10/business/10dengue-web/10dengue-web-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/10/business/10dengue-web/10dengue-web-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""First Dengue Fever Vaccine Approved by Mexico"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Mexico Approves Dengue Fever Vaccine"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""glocations"", ""value"": ""Mexico"", ""rank"": 1, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 2, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Vaccination and Immunization"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Dengue Fever"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 5, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""Hawaii"", ""rank"": 6, ""major"": ""N""}], ""pub_date"": ""2015-12-09T17:17:02+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/e907424f-9825-5ab7-aca2-dd58150cdca7"", ""word_count"": 691, ""uri"": ""nyt://article/e907424f-9825-5ab7-aca2-dd58150cdca7""}"
2015-12-15,"{""abstract"": ""The exchange of business units would make Sanofi one of the world\u2019s largest manufacturers of nonprescription medicines."", ""web_url"": ""https://www.nytimes.com/2015/12/16/business/dealbook/sanofi-boehringer-asset-swap.html"", ""snippet"": ""The exchange of business units would make Sanofi one of the world\u2019s largest manufacturers of nonprescription medicines."", ""lead_paragraph"": ""LONDON \u2014 The French pharmaceutical company Sanofi and the German drug maker Boehringer Ingelheim said on Tuesday that they were in \u201cexclusive negotiations\u201d on a potential asset swap that would make Sanofi one of the world\u2019s largest manufacturers of nonprescription medicines."", ""print_section"": ""B"", ""print_page"": ""5"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-articleLarge.jpg"", ""height"": 337, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 337}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-jumbo.jpg"", ""height"": 574, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-superJumbo.jpg"", ""height"": 1149, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2015/12/16/business/16DB-Sanofi/16DB-Sanofi-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""European Drug Makers Sanofi and Boehringer Ingelheim in Talks"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Two European Drug Makers in Talks About Asset Swaps"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 1, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Bray, Chad"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Boehringer Ingelheim GmbH"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 5, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Merial Animal Health"", ""rank"": 6, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Brandicourt, Olivier"", ""rank"": 7, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Zoetis Inc"", ""rank"": 8, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Pfizer Inc"", ""rank"": 9, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""France"", ""rank"": 10, ""major"": ""N""}, {""name"": ""glocations"", ""value"": ""Germany"", ""rank"": 11, ""major"": ""N""}], ""pub_date"": ""2015-12-15T10:18:18+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Chad Bray"", ""person"": [{""firstname"": ""Chad"", ""middlename"": null, ""lastname"": ""Bray"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/f40f6462-6b90-5091-ba69-d52bcfb464cb"", ""word_count"": 465, ""uri"": ""nyt://article/f40f6462-6b90-5091-ba69-d52bcfb464cb""}"
2016-01-05,"{""abstract"": ""The insulin, called Afrezza, has had poor sales since being approved by the F.D.A. in 2014. Shares in its maker, MannKind, fell 48 percent."", ""web_url"": ""https://www.nytimes.com/2016/01/06/business/sanofi-ends-marketing-deal-with-developer-of-inhaled-insulin.html"", ""snippet"": ""The insulin, called Afrezza, has had poor sales since being approved by the F.D.A. in 2014. Shares in its maker, MannKind, fell 48 percent."", ""lead_paragraph"": ""An inhaled insulin championed by a billionaire medical entrepreneur suffered a big setback on Tuesday when it was abandoned by the company with the rights to market it."", ""print_section"": ""B"", ""print_page"": ""2"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/01/06/business/06Insulin/06Insulin-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2016/01/06/business/06Insulin/06Insulin-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/01/06/business/06Insulin/06Insulin-jumbo.jpg"", ""height"": 683, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/01/06/business/06Insulin/06Insulin-superJumbo.jpg"", ""height"": 1367, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/01/06/business/06Insulin/06Insulin-thumbStandard-v2.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2016/01/06/business/06Insulin/06Insulin-thumbStandard-v2.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/01/06/business/06Insulin/06Insulin-thumbLarge-v2.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Sanofi Ends Marketing Deal With Developer of Inhaled Insulin"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Shares of Inhaled Insulin Maker Plummet 48% as Big Marketing Partner Pulls Out"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""MannKind Corporation"", ""rank"": 3, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Mann, Alfred E"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Pfizer Inc"", ""rank"": 5, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Food and Drug Administration"", ""rank"": 6, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Diabetes"", ""rank"": 7, ""major"": ""N""}], ""pub_date"": ""2016-01-05T18:05:34+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/1f3fccb0-77a0-591c-af2e-ccbebd991606"", ""word_count"": 914, ""uri"": ""nyt://article/1f3fccb0-77a0-591c-af2e-ccbebd991606""}"
2016-04-28,"{""abstract"": ""Sanofi said that it made a private offer to acquire the prostate cancer drug maker nearly two weeks ago but did not receive a response."", ""web_url"": ""https://www.nytimes.com/2016/04/29/business/dealbook/sanofi-france-offers-buy-drug-maker-medivation.html"", ""snippet"": ""Sanofi said that it made a private offer to acquire the prostate cancer drug maker nearly two weeks ago but did not receive a response."", ""lead_paragraph"": ""The French drug company Sanofi said on Thursday that it had made a nonbinding offer to acquire the prostate cancer drug maker Medivation for about $9.3 billion in cash."", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-articleLarge.jpg"", ""height"": 400, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 400}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-jumbo.jpg"", ""height"": 683, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-superJumbo.jpg"", ""height"": 1365, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/29/business/29db-sanofi1/29db-sanofi1-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Sanofi Offers to Buy Drug Maker Medivation for $9.3 Billion"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Medivation Inc"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 4, ""major"": ""N""}], ""pub_date"": ""2016-04-28T07:55:45+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Chad Bray and Andrew Pollack"", ""person"": [{""firstname"": ""Chad"", ""middlename"": null, ""lastname"": ""Bray"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}, {""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 2}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/8f950da1-1573-5366-83a2-53e394adfea1"", ""word_count"": 941, ""uri"": ""nyt://article/8f950da1-1573-5366-83a2-53e394adfea1""}"
2016-04-29,"{""abstract"": ""Pressured by a proposal made directly to Medivation\u2019s shareholders, the company said the $9.3 billion offer \u201csubstantially undervalues Medivation.\u201d"", ""web_url"": ""https://www.nytimes.com/2016/04/30/business/dealbook/medivation-rejects-takeover-bid-from-sanofi.html"", ""snippet"": ""Pressured by a proposal made directly to Medivation\u2019s shareholders, the company said the $9.3 billion offer \u201csubstantially undervalues Medivation.\u201d"", ""lead_paragraph"": ""Medivation, which makes drugs for prostate cancer, has a message for the French drug company Sanofi: The $9.3 billion cash takeover offer was not good enough."", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-articleLarge.jpg"", ""height"": 401, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 401}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-jumbo.jpg"", ""height"": 684, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-superJumbo.jpg"", ""height"": 1368, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/04/30/business/30DB-SANOFI/30DB-SANOFI-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Medivation Rejects Takeover Bid From Sanofi"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Medivation Inc"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 3, ""major"": ""N""}], ""pub_date"": ""2016-04-29T15:18:34+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Leslie Picker"", ""person"": [{""firstname"": ""Leslie"", ""middlename"": null, ""lastname"": ""Picker"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/27ad6ac0-64d4-5e85-8eb3-32b8320c69d2"", ""word_count"": 388, ""uri"": ""nyt://article/27ad6ac0-64d4-5e85-8eb3-32b8320c69d2""}"
2016-05-05,"{""abstract"": ""The French drugmaker said it believed it had \u201coverwhelming support\u201d from Medivation\u2019s shareholders for a merger, and Medivation still said no."", ""web_url"": ""https://www.nytimes.com/2016/05/06/business/dealbook/sanofi-threatens-to-take-medivation-offer-to-shareholders.html"", ""snippet"": ""The French drugmaker said it believed it had \u201coverwhelming support\u201d from Medivation\u2019s shareholders for a merger, and Medivation still said no."", ""lead_paragraph"": ""LONDON \u2014 The French drug company Sanofi and Medivation, a California company that makes a prostate cancer drug, traded volleys on Thursday in a contentious takeover fight."", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Sanofi Trades Volleys With Medivation in $9.3 Billion Offer"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Medivation Inc"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 3, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Brandicourt, Olivier"", ""rank"": 4, ""major"": ""N""}], ""pub_date"": ""2016-05-05T13:57:11+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Chad Bray"", ""person"": [{""firstname"": ""Chad"", ""middlename"": null, ""lastname"": ""Bray"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/4d4d07e6-e23f-5a4a-b729-e745426c5914"", ""word_count"": 409, ""uri"": ""nyt://article/4d4d07e6-e23f-5a4a-b729-e745426c5914""}"
2016-05-25,"{""abstract"": ""The French drug maker said it was seeking the consent of the American company\u2019s shareholders to replace directors with a slate of its own candidates."", ""web_url"": ""https://www.nytimes.com/2016/05/26/business/dealbook/sanofi-to-seek-removal-of-medivation-board-in-takeover-fight.html"", ""snippet"": ""The French drug maker said it was seeking the consent of the American company\u2019s shareholders to replace directors with a slate of its own candidates."", ""lead_paragraph"": ""LONDON \u2014 The French pharmaceutical company Sanofi said on Wednesday that it would seek to replace the board of Medivation after the American drug maker\u2019s directors rejected a $9.3 billion takeover offer."", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Sanofi to Seek Removal of Medivation Board in Takeover Fight"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Boards of Directors"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 3, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Medivation Inc"", ""rank"": 4, ""major"": ""N""}, {""name"": ""persons"", ""value"": ""Brandicourt, Olivier"", ""rank"": 5, ""major"": ""N""}], ""pub_date"": ""2016-05-25T13:23:10+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Chad Bray"", ""person"": [{""firstname"": ""Chad"", ""middlename"": null, ""lastname"": ""Bray"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/38249854-888a-5ca4-8dd7-eed3ec62202f"", ""word_count"": 526, ""uri"": ""nyt://article/38249854-888a-5ca4-8dd7-eed3ec62202f""}"
2016-05-27,"{""abstract"": ""A look at the most significant deals provides a lesson in how hostile takeovers work and how would-be acquirers often make common mistakes."", ""web_url"": ""https://www.nytimes.com/2016/05/28/business/dealbook/hostile-takeovers-abound-but-success-is-no-guarantee.html"", ""snippet"": ""A look at the most significant deals provides a lesson in how hostile takeovers work and how would-be acquirers often make common mistakes."", ""lead_paragraph"": ""Assumed dead after Air Products and Chemicals failed to take over Airgas, hostile takeovers seem to be again sprouting up everywhere."", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Hostile Takeovers Abound, but Success Is No Guarantee"", ""kicker"": ""Deal Professor"", ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Shareholder Rights and Activism"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Tribune Publishing Company"", ""rank"": 3, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Gannett Company Inc"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Medivation Inc"", ""rank"": 5, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 6, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Monsanto Company"", ""rank"": 7, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Bayer AG"", ""rank"": 8, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Westlake Chemical Corporation"", ""rank"": 9, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Axiall Corp."", ""rank"": 10, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Andersons Inc"", ""rank"": 11, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""HC2 Holdings Inc"", ""rank"": 12, ""major"": ""N""}], ""pub_date"": ""2016-05-27T19:11:01+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Steven Davidoff Solomon"", ""person"": [{""firstname"": ""Steven"", ""middlename"": ""Davidoff"", ""lastname"": ""Solomon"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/ae41cd8d-79ed-5f97-b15a-121d72ee5a01"", ""word_count"": 1422, ""uri"": ""nyt://article/ae41cd8d-79ed-5f97-b15a-121d72ee5a01""}"
2016-08-25,"{""abstract"": ""Mylan\u2019s price increases for the allergy treatment device highlight a common tactic in the industry: raising prices just before a generic competitor reaches the market."", ""web_url"": ""https://www.nytimes.com/2016/08/25/business/mylan-raised-epipens-price-before-the-expected-arrival-of-a-generic.html"", ""snippet"": ""Mylan\u2019s price increases for the allergy treatment device highlight a common tactic in the industry: raising prices just before a generic competitor reaches the market."", ""lead_paragraph"": ""In 2012, the company behind the EpiPen settled a lawsuit by agreeing to allow a generic competitor into the market in 2015, potentially cutting into a big part of its business."", ""print_section"": ""B"", ""print_page"": ""1"", ""source"": ""The New York Times"", ""multimedia"": [{""rank"": 0, ""subtype"": ""xlarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/08/25/business/25EPPEN/25EPPEN-articleLarge.jpg"", ""height"": 399, ""width"": 600, ""subType"": ""xlarge"", ""crop_name"": ""articleLarge"", ""legacy"": {""xlarge"": ""images/2016/08/25/business/25EPPEN/25EPPEN-articleLarge.jpg"", ""xlargewidth"": 600, ""xlargeheight"": 399}}, {""rank"": 0, ""subtype"": ""jumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/08/25/business/25EPPEN/25EPPEN-jumbo.jpg"", ""height"": 681, ""width"": 1024, ""subType"": ""jumbo"", ""crop_name"": ""jumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""superJumbo"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/08/25/business/25EPPEN/25EPPEN-superJumbo.jpg"", ""height"": 1363, ""width"": 2048, ""subType"": ""superJumbo"", ""crop_name"": ""superJumbo"", ""legacy"": {}}, {""rank"": 0, ""subtype"": ""thumbnail"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/08/25/business/25EPPEN/25EPPEN-thumbStandard.jpg"", ""height"": 75, ""width"": 75, ""subType"": ""thumbnail"", ""crop_name"": ""thumbStandard"", ""legacy"": {""thumbnail"": ""images/2016/08/25/business/25EPPEN/25EPPEN-thumbStandard.jpg"", ""thumbnailwidth"": 75, ""thumbnailheight"": 75}}, {""rank"": 0, ""subtype"": ""thumbLarge"", ""caption"": null, ""credit"": null, ""type"": ""image"", ""url"": ""images/2016/08/25/business/25EPPEN/25EPPEN-thumbLarge.jpg"", ""height"": 150, ""width"": 150, ""subType"": ""thumbLarge"", ""crop_name"": ""thumbLarge"", ""legacy"": {}}], ""headline"": {""main"": ""Mylan Raised EpiPen\u2019s Price Before the Expected Arrival of a Generic"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": ""Last Shot at EpiPen Profits Ends in a Mylan Monopoly"", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""persons"", ""value"": ""Pollack, Andrew"", ""rank"": 1, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Mylan Inc"", ""rank"": 2, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Prices (Fares, Fees and Rates)"", ""rank"": 3, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Generic Brands and Products"", ""rank"": 4, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Medical Devices"", ""rank"": 5, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 6, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Food and Drug Administration"", ""rank"": 7, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 8, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Epinephrine (Drug)"", ""rank"": 9, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""ALLERGIES"", ""rank"": 10, ""major"": ""N""}], ""pub_date"": ""2016-08-25T00:21:05+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""byline"": {""original"": ""By Andrew Pollack"", ""person"": [{""firstname"": ""Andrew"", ""middlename"": null, ""lastname"": ""Pollack"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/aee18876-71ab-5d93-850b-a6f63adba8f2"", ""word_count"": 1146, ""uri"": ""nyt://article/aee18876-71ab-5d93-850b-a6f63adba8f2""}"
2016-12-21,"{""abstract"": ""They both cautioned that there was no assurance that an actual transaction would be signed as a result of these talks."", ""web_url"": ""https://www.nytimes.com/2016/12/21/business/dealbook/johnson-johnson-and-actelion-confirm-merger-talks-are-back-on.html"", ""snippet"": ""They both cautioned that there was no assurance that an actual transaction would be signed as a result of these talks."", ""lead_paragraph"": ""Johnson & Johnson has resumed acquisition talks with Actelion Pharmaceuticals, the $20 billion Swiss biopharmaceutical company, after announcing just last week that it was severing discussions over a deal."", ""source"": ""The New York Times"", ""multimedia"": [], ""headline"": {""main"": ""Johnson & Johnson and Actelion Confirm Merger Talks Are Back On"", ""kicker"": null, ""content_kicker"": null, ""print_headline"": """", ""name"": null, ""seo"": null, ""sub"": null}, ""keywords"": [{""name"": ""subject"", ""value"": ""Mergers, Acquisitions and Divestitures"", ""rank"": 1, ""major"": ""N""}, {""name"": ""subject"", ""value"": ""Drugs (Pharmaceuticals)"", ""rank"": 2, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Johnson & Johnson"", ""rank"": 3, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Actelion Pharmaceuticals Ltd"", ""rank"": 4, ""major"": ""N""}, {""name"": ""organizations"", ""value"": ""Sanofi SA"", ""rank"": 5, ""major"": ""N""}], ""pub_date"": ""2016-12-21T19:17:19+0000"", ""document_type"": ""article"", ""news_desk"": ""Business"", ""section_name"": ""Business Day"", ""subsection_name"": ""DealBook"", ""byline"": {""original"": ""By Leslie Picker"", ""person"": [{""firstname"": ""Leslie"", ""middlename"": null, ""lastname"": ""Picker"", ""qualifier"": null, ""title"": null, ""role"": ""reported"", ""organization"": """", ""rank"": 1}], ""organization"": null}, ""type_of_material"": ""News"", ""_id"": ""nyt://article/be2d4587-11be-5d36-973e-e73cc2ec83ca"", ""word_count"": 261, ""uri"": ""nyt://article/be2d4587-11be-5d36-973e-e73cc2ec83ca""}"
